循环肿瘤细胞与生物标志物：对转移性乳腺癌个性化靶向治疗的意义 - Suppr

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.

作者信息

Reuben James M, Lee Bang-Ning, Li Changping, Gao Hui, Broglio Kristine R, Valero Vicente, Jackson Summer A, Ueno Naoto T, Krishnamurthy Savitri, Hortobagyi Gabriel N, Cristofanilli Massimo

出版信息

Breast J. 2010 May-Jun;16(3):327-30. doi: 10.1111/j.1524-4741.2010.00910.x. Epub 2010 Apr 12.

DOI:10.1111/j.1524-4741.2010.00910.x

PMID:20408820

Abstract

摘要

相似文献

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.

Breast J. 2010 May-Jun;16(3):327-30. doi: 10.1111/j.1524-4741.2010.00910.x. Epub 2010 Apr 12.

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

Gynecol Oncol. 2011 Aug;122(2):356-60. doi: 10.1016/j.ygyno.2011.04.039. Epub 2011 May 24.

Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.

J Natl Cancer Inst. 2008 Feb 6;100(3):159-61. doi: 10.1093/jnci/djm325. Epub 2008 Jan 29.

Biomarker update for breast, colorectal and non-small cell lung cancer.

Drug News Perspect. 2010 Jan-Feb;23(1):82-8. doi: 10.1358/dnp.2010.23.1.1437316.

[Biological features of breast cancer in patients under 35].

Vopr Onkol. 2007;53(6):674-6.

[Pharmaceutical therapy of breast cancer].

Magy Onkol. 2010 Sep;54(3):237-54. doi: 10.1556/MOnkol.54.2010.3.5.

Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.

S D Med. 2010 Jul;63(7):247-53.

High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: true or false?

Breast J. 2006 Sep-Oct;12(5):499-501. doi: 10.1111/j.1075-122X.2006.00315.x.

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy.

J BUON. 2013 Jan-Mar;18(1):289.

[Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].

Rev Esp Med Nucl. 2000 Jun;19(3):244-6.

引用本文的文献

Exploring the Role of Epithelial-Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review.

Cancers (Basel). 2025 Feb 5;17(3):529. doi: 10.3390/cancers17030529.

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.

Cancers (Basel). 2023 Mar 6;15(5):1616. doi: 10.3390/cancers15051616.

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.

Clin Cancer Res. 2017 Sep 15;23(18):5358-5365. doi: 10.1158/1078-0432.CCR-16-2748. Epub 2017 May 24.

Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.

Clin Transl Oncol. 2017 Sep;19(9):1125-1132. doi: 10.1007/s12094-017-1649-7. Epub 2017 Mar 17.

Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.

Oncotarget. 2017 Jan 10;8(2):3029-3041. doi: 10.18632/oncotarget.13823.

Circulating tumor cells in newly diagnosed inflammatory breast cancer.

Breast Cancer Res. 2015 Jan 9;17(1):2. doi: 10.1186/s13058-014-0507-6.

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Nat Rev Clin Oncol. 2013 Jul;10(7):377-89. doi: 10.1038/nrclinonc.2013.80. Epub 2013 May 28.

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

Mol Cancer Ther. 2012 Nov;11(11):2526-34. doi: 10.1158/1535-7163.MCT-12-0460. Epub 2012 Sep 12.

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.

Breast Cancer Res. 2011 Jun 15;13(3):R67. doi: 10.1186/bcr2907.

Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.

Breast Cancer Res Treat. 2011 Jul;128(1):155-63. doi: 10.1007/s10549-011-1508-0. Epub 2011 Apr 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献